Total Payments
$6,483
2024 Payments
$3,534
Companies
48
Transactions
231
Medicare Patients
8,617
Medicare Billing
$295,660
Payment Breakdown by Category
Food & Beverage$4,586 (70.7%)
Other$1,299 (20.0%)
Education$597.75 (9.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,586 | 210 | 70.7% |
| Long term medical supply or device loan | $1,299 | 15 | 20.0% |
| Education | $597.75 | 6 | 9.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,446 | 27 | $0 (2024) |
| ABBVIE INC. | $454.05 | 14 | $0 (2024) |
| Janssen Biotech, Inc. | $362.46 | 8 | $0 (2024) |
| Lilly USA, LLC | $328.36 | 15 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $316.67 | 8 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $314.02 | 15 | $0 (2024) |
| GlaxoSmithKline, LLC. | $249.92 | 9 | $0 (2024) |
| PFIZER INC. | $227.58 | 15 | $0 (2024) |
| Pharmacyclics LLC, An AbbVie Company | $218.42 | 8 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $183.12 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,534 | 126 | Novartis Pharmaceuticals Corporation ($1,061) |
| 2023 | $1,597 | 59 | Novartis Pharmaceuticals Corporation ($356.77) |
| 2022 | $674.56 | 25 | E.R. Squibb & Sons, L.L.C. ($125.65) |
| 2021 | $677.29 | 21 | BeiGene USA, Inc. ($115.05) |
All Payment Transactions
231 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/18/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Oncology | ||||||
| 12/13/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Oncology | ||||||
| 12/11/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $7.31 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $83.33 | General |
| Category: Oncology | ||||||
| 12/05/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 11/27/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological) | Food and Beverage | In-kind items and services | $39.35 | General |
| Category: Oncology | ||||||
| 11/25/2024 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: ONCOLOGY | ||||||
| 11/20/2024 | Stemline Therapeutics Inc. | ELZONRIS (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Oncology | ||||||
| 11/15/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $79.15 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2024 | ABBVIE INC. | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $83.33 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Oncology | ||||||
| 11/11/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $30.54 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $29.79 | General |
| Category: NONE | ||||||
| 10/30/2024 | Merck Sharp & Dohme LLC | WELIREG (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $97.03 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Oncology | ||||||
| 10/25/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $30.02 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2024 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $21.92 | General |
| Category: Oncology | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $83.33 | General |
| Category: Oncology | ||||||
| 10/15/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $2.43 | General |
| Category: NONE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,601 | 3,920 | $427,696 | $91,691 |
| 2022 | 30 | 2,501 | 3,528 | $358,872 | $74,034 |
| 2021 | 23 | 1,961 | 3,199 | $363,167 | $78,989 |
| 2020 | 19 | 1,554 | 2,246 | $262,826 | $50,947 |
Total Patients
8,617
Total Services
12,893
Medicare Billing
$295,660
Procedure Codes
93
All Medicare Procedures & Services
93 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 269 | 394 | $144,992 | $30,795 | 21.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 316 | 404 | $101,000 | $21,495 | 21.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 70 | 77 | $38,192 | $8,920 | 23.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 440 | 688 | $44,032 | $7,104 | 16.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 454 | 767 | $15,340 | $6,443 | 42.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 432 | 707 | $25,452 | $5,368 | 21.1% |
| 85055 | Reticulated (young) platelet measurement | Office | 2023 | 39 | 50 | $7,150 | $1,752 | 24.5% |
| 82784 | Gammaglobulin (immune system protein) measurement | Office | 2023 | 44 | 162 | $9,072 | $1,476 | 16.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $8,475 | $1,403 | 16.6% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 81 | 104 | $6,240 | $1,378 | 22.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $6,324 | $1,160 | 18.3% |
| 83550 | Iron binding capacity | Office | 2023 | 75 | 96 | $3,360 | $815.42 | 24.3% |
| 82378 | Carcinoembryonic antigen (cea) protein level | Office | 2023 | 27 | 35 | $3,465 | $650.30 | 18.8% |
| 83540 | Iron level | Office | 2023 | 76 | 97 | $2,619 | $609.58 | 23.3% |
| 83735 | Magnesium level | Office | 2023 | 54 | 75 | $2,175 | $492.75 | 22.7% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 27 | 28 | $2,128 | $413.84 | 19.4% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 15 | 22 | $2,068 | $396.44 | 19.2% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 43 | 56 | $1,904 | $355.04 | 18.6% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2023 | 51 | 53 | $1,643 | $313.76 | 19.1% |
| 85007 | Microscopic examination for white blood cells with manual cell count | Office | 2023 | 43 | 56 | $1,232 | $208.32 | 16.9% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 13 | 17 | $833.00 | $140.93 | 16.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 313 | 392 | $98,000 | $21,194 | 21.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 187 | 250 | $92,000 | $19,618 | 21.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 366 | 537 | $34,368 | $5,586 | 16.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 43 | 46 | $22,816 | $5,427 | 23.8% |
About Tiffiney Mcmakin, NP
Tiffiney Mcmakin, NP is a Family healthcare provider based in Tyler, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/22/2019. The National Provider Identifier (NPI) number assigned to this provider is 1679116610.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Tiffiney Mcmakin, NP has received a total of $6,483 in payments from pharmaceutical and medical device companies, with $3,534 received in 2024. These payments were reported across 231 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($4,586).
As a Medicare-enrolled provider, Mcmakin has provided services to 8,617 Medicare beneficiaries, totaling 12,893 services with total Medicare billing of $295,660. Data is available for 4 years (2020–2023), covering 93 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Tyler, TX
- Active Since 10/22/2019
- Last Updated 09/28/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1679116610
Products in Payments
- KISQALI (Drug) $1,102
- IMBRUVICA (Drug) $386.79
- MYRISK (Device) $316.67
- SARCLISA (Biological) $210.59
- VERZENIO (Drug) $198.87
- MONJUVI (Drug) $183.76
- LIBTAYO (Biological) $183.12
- IMJUDO (Biological) $181.99
- EPKINLY (Drug) $177.10
- XT CDX (Device) $158.98
- BRUKINSA (Drug) $137.78
- DARZALEX (Biological) $134.83
- JEMPERLI (Biological) $127.83
- OPDIVO (Biological) $125.65
- TECVAYLI (Biological) $123.49
- IMFINZI (Biological) $113.51
- ZEJULA (Drug) $91.96
- IBRANCE (Drug) $81.56
- FRUZAQLA (Drug) $79.15
- XPOVIO (Drug) $74.50
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Tyler
Jonathan King, Np, NP
Family — Payments: $83,965
Family $83,965
Kirsten Stuber, Fnp-Bc, FNP-BC
Family — Payments: $66,199
Family $66,199
Machelle Mcdowell, Fnp, Np-C, FNP, NP-C
Family — Payments: $63,178
Family $63,178
Amanda George, Aprn, Bc Fnp, APRN, BC FNP
Family — Payments: $8,588
Family $8,588
Brandi Dunford, Fnp-C, FNP-C
Family — Payments: $6,695
Family $6,695
Natalye Combs, Msn, Aprn, Fnp-C, MSN, APRN, FNP-C
Family — Payments: $6,338
Family $6,338